NanoSpy Inc..jpg


Darin Heisterkamp, President

nanospy, inc

NanoSpy introduces the new state-of-the-art in rapid pathogen detection biosensors. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, and nanomaterials to dramatically simplify the detection process with a new paradigm in biosensor platforms. For food processing companies who must protect their product against pathogen contamination, NanoSpy provides an on-site rapid detection method that is highly sensitive (down to 5 CFU/mL or less ), highly specific (no false positives or false negatives), supports a variety of sample matrices, and gets results in less than 20 minutes, all without a laboratory or time-consuming bacteria enrichment process.